RNS Number : 2860U

Societe Generale SA

01 April 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	31/03/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	890,390	0.69	6,395	0.00
(2) Derivatives (other than options)	181,476	0.14	768,247	0.60
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,629,056	*1.26	774,642	0.60

* Include the holding of shares 557,190 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	19	229.16
Purchase	38	229.09
Purchase	38	229.18
Purchase	38	229.08
Purchase	100	229.51
Purchase	596	228.88
Purchase	3,405	228.88
Purchase	9	229.14
Purchase	14	229.04
Purchase	100	228.97
Purchase	4	229.08
Purchase	7	229.08
Purchase	100	230.65
Purchase	100	228.99
Purchase	11	228.94
Purchase	100	229.18
Purchase	24	229.03
Purchase	380	228.88
Sale	76	231.84
Sale	30	231.84
Sale	2	229.01
Sale	10	229.01
Sale	3	229.01
Sale	18	229.01
Sale	31	229.73
Sale	100	229.38
Sale	68	232.1
Sale	32	232.1
Sale	3	231.25
Sale	2	231.2
Sale	86	230.67
Sale	30	231.3
Sale	100	231.15
Sale	16	230
Sale	2	229.95
Sale	24	230
Sale	36	230
Sale	1	229.58
Sale	1	229.58
Sale	24	230
Sale	2	229.94
Sale	30	229.95
Sale	36	230.21
Sale	34	229.97
Sale	22	229.62
Sale	1	229.62
Sale	24	230
Sale	19	230.57
Sale	20	229.58
Sale	1	229.58
Sale	4	229.65
Sale	36	229.45
Sale	1	229.62
Sale	17	229.63
Sale	3	229.63
Sale	20	229.65
Sale	35	229.94
Sale	10	229.95
Sale	36	230
Sale	20	230
Sale	3	229.63
Sale	10	229.75
Sale	1	229.63
Sale	24	229.79
Sale	10	229.91
Sale	24	229.9
Sale	36	229.9
Sale	16	229.53
Sale	4	229.61
Sale	7	229.52
Sale	1	229.61
Sale	1	229.61
Sale	2	230.02
Sale	14	229.9
Sale	1	229.53
Sale	5	229.52
Sale	1	229.52
Sale	4	230.02
Sale	19	229.61
Sale	18	230.02
Sale	8	229.67
Sale	22	230.65
Sale	18	230.65
Sale	1	230.62
Sale	36	230.62
Sale	14	229.8
Sale	24	229.92
Sale	30	230.22
Sale	30	230.22
Sale	1	229.78
Sale	15	229.79
Sale	36	229.8
Sale	7	229.78
Sale	1	229.78
Sale	16	229.68
Sale	2	230.65
Sale	36	230.65
Sale	24	230.65
Sale	17	230.62
Sale	36	230.62
Sale	6	230.21
Sale	6	230.21
Sale	1	230.04
Sale	7	230.4
Sale	35	230.04
Sale	2	229.95
Sale	6	229.94
Sale	26	229.94
Sale	30	229.96
Sale	1	229.94
Sale	2	229.97
Sale	36	230
Sale	1	229.58
Sale	4	229.05
Sale	4	229.05
Sale	2,158	229.05
Sale	12	231.84
Sale	12	231.64
Sale	9	231.64
Sale	14	230.67
Sale	348	228.88
Sale	532	228.88
Sale	1,140	228.88
Total Purchases	5,083
Total Sales	6,033

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit USD (Note 5)
CFD	Decreased Short	1,209	230.0199

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	01/04/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFSDSRILIIL